Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 2
2009 2
2010 5
2011 2
2013 1
2015 2
2016 3
2017 4
2018 3
2019 2
2020 3
2021 8
2022 7
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME; RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group. Yao JC, et al. Among authors: lahner h. Lancet. 2016 Mar 5;387(10022):968-977. doi: 10.1016/S0140-6736(15)00817-X. Epub 2015 Dec 17. Lancet. 2016. PMID: 26703889 Free PMC article. Clinical Trial.
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study.
Remde H, Schmidt-Pennington L, Reuter M, Landwehr LS, Jensen M, Lahner H, Kimpel O, Altieri B, Laubner K, Schreiner J, Bojunga J, Kircher S, Kunze CA, Pohrt A, Teleanu MV, Hübschmann D, Stenzinger A, Glimm H, Fröhling S, Fassnacht M, Mai K, Kroiss M. Remde H, et al. Among authors: lahner h. Eur J Endocrinol. 2023 Jun 7;188(6):485-493. doi: 10.1093/ejendo/lvad054. Eur J Endocrinol. 2023. PMID: 37260092
[Oncological theranostics in nuclear medicine].
Laschinsky C, Herrmann K, Fendler W, Nader M, Lahner H, Hadaschik B, Sandach P. Laschinsky C, et al. Among authors: lahner h. Radiologie (Heidelb). 2022 Oct;62(10):875-884. doi: 10.1007/s00117-022-01072-w. Radiologie (Heidelb). 2022. PMID: 36112174 German.
Hedinger Syndrome-Lessons Learnt: A Single-Center Experience.
El Gabry M, Arends S, Shehada SE, Lahner H, Kamler M, Wendt D, Spetsotaki K. El Gabry M, et al. Among authors: lahner h. J Cardiovasc Dev Dis. 2023 Oct 1;10(10):413. doi: 10.3390/jcdd10100413. J Cardiovasc Dev Dis. 2023. PMID: 37887860 Free PMC article.
Artificial Sepsis: Think Twice Before Pausing Therapy.
Mathew A, Führer D, Lahner H. Mathew A, et al. Among authors: lahner h. Am J Med. 2022 Mar;135(3):e73-e74. doi: 10.1016/j.amjmed.2021.10.006. Epub 2021 Oct 28. Am J Med. 2022. PMID: 34717899 No abstract available.
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.
Weber M, Pettersson O, Seifert R, Schaarschmidt BM, Fendler WP, Rischpler C, Lahner H, Herrmann K, Sundin A. Weber M, et al. Among authors: lahner h. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):841-851. doi: 10.1007/s00259-023-06502-y. Epub 2023 Nov 10. Eur J Nucl Med Mol Imaging. 2024. PMID: 37947848 Free PMC article.
46 results